FDA Inspection 1190666 — CSL Plasma, Inc.

CSL Plasma, Inc. — FEI 1072730

The FDA completed an inspection of CSL Plasma, Inc. on November 2, 2022 in Pensacola, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 2, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Pensacola, FL (United States)